{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:58:07Z","timestamp":1791565087633,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["978587"],"award-info":[{"award-number":["978587"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-023-02105-7","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T04:01:50Z","timestamp":1689998510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Inhibition of IRE1 RNase activity modulates tumor cell progression and enhances the response to chemotherapy in colorectal cancer"],"prefix":"10.1007","volume":"40","author":[{"given":"Sana","family":"Abbasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helia","family":"Rivand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Eshaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin","family":"Moosavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Amanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4417-4259","authenticated-orcid":false,"given":"Michael F.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2676-3973","authenticated-orcid":false,"given":"Marveh","family":"Rahmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,22]]},"reference":[{"issue":"2","key":"2105_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5114\/pg.2018.81072","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89\u2013103. https:\/\/doi.org\/10.5114\/pg.2018.81072.","journal-title":"Prz Gastroenterol"},{"issue":"9863","key":"2105_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(12)61900-X","volume":"26","author":"A Grothey","year":"2013","unstructured":"Grothey A, Van Cutsem E, Sobrero A, Siena S, Falcone A, Ychou M, et al. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet. 2013;26(9863):303\u201312. https:\/\/doi.org\/10.1016\/S0140-6736(12)61900-X.","journal-title":"Lancet"},{"issue":"13","key":"2105_CR3","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1200\/JCO.2006.09.0928","volume":"1","author":"A Falcone","year":"2007","unstructured":"Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrine G, Barbara C, et al. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the gruppo oncologico nor. J Clin Oncol. 2007;1(13):1670\u20136. https:\/\/doi.org\/10.1200\/JCO.2006.09.0928.","journal-title":"J Clin Oncol"},{"issue":"6","key":"2105_CR4","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1007\/s11033-022","volume":"49","author":"FD Pouya","year":"2022","unstructured":"Pouya FD, Gazouli M, Rasmi Y, Lampropoulou DI, Nemati M. MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil. Mol Biol Rep. 2022;49(6):5165\u201378. https:\/\/doi.org\/10.1007\/s11033-022-07227-1.","journal-title":"Mol Biol Rep"},{"issue":"3","key":"2105_CR5","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3892\/or.2015.4108","volume":"34","author":"M De Rosa","year":"2015","unstructured":"De Rosa M, Pace U, Rega D, Costabile V, Duraturo F, Izzo P, et al. Genetics, diagnosis and management of colorectal cancer (review). Oncol Rep. 2015;34(3):1087\u201396. https:\/\/doi.org\/10.3892\/or.2015.4108.","journal-title":"Oncol Rep"},{"key":"2105_CR6","doi-asserted-by":"publisher","first-page":"620514","DOI":"10.3389\/fmolb.2021.620514","volume":"8","author":"S Cao","year":"2021","unstructured":"Cao S, Tang J, Huang Y, Li G, Li Z, Cai W, et al. The road of solid tumor survival: from drug-induced endoplasmic reticulum stress to drug resistance. Front Mol Biosci. 2021;8:620514. https:\/\/doi.org\/10.3389\/fmolb.2021.620514.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"2105_CR7","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1002\/cti2.1007","volume":"7","author":"N Nikesitch","year":"2018","unstructured":"Nikesitch N, Lee JM, Ling S, Roberts TL. Endoplasmic reticulum stress in the development of multiple myeloma and drug resistance. Clin Transl Immunol. 2018;7(1):e1007. https:\/\/doi.org\/10.1002\/cti2.1007.","journal-title":"Clin Transl Immunol"},{"key":"2105_CR8","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/s0092-8674(01)00611-0","volume":"107","author":"H Yoshida","year":"2001","unstructured":"Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K. XBP1 mRNA is Induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell. 2001;107:881\u201391. https:\/\/doi.org\/10.1016\/s0092-8674(01)00611-0.","journal-title":"Cell"},{"issue":"2","key":"2105_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrm3270","volume":"13","author":"C Hetz","year":"2012","unstructured":"Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 2012;13(2):89\u2013102. https:\/\/doi.org\/10.1038\/nrm3270.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"2105_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.molcel.2017.06.017","volume":"69","author":"C Hetz","year":"2018","unstructured":"Hetz C, Papa FR. The unfolded protein response and cell fate control. Mol Cell. 2018;69(2):169\u201381. https:\/\/doi.org\/10.1016\/j.molcel.2017.06.017.","journal-title":"Mol Cell"},{"issue":"9","key":"2105_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrc3800","volume":"14","author":"M Wang","year":"2014","unstructured":"Wang M, Kaufman RJ. The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat Rev Cancer. 2014;14(9):581\u201397. https:\/\/doi.org\/10.1038\/nrc3800.","journal-title":"Nat Rev Cancer"},{"key":"2105_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-pathol-012513-104649","volume":"10","author":"SA Oakes","year":"2015","unstructured":"Oakes SA, Papa FR. The role of endoplasmic reticulum stress in human pathology. Annu Rev Pathol Mech Dis. 2015;10:173\u201394. https:\/\/doi.org\/10.1146\/annurev-pathol-012513-104649.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"2105_CR13","doi-asserted-by":"publisher","first-page":"105572","DOI":"10.1016\/j.biocel.2019.105572","volume":"114","author":"Y Xie","year":"2019","unstructured":"Xie Y, Liu C, Qin Y, Chen J, Fang J. Knockdown of IRE1\u0251 suppresses metastatic potential of colon cancer cells through inhibiting FN1-Src\/FAK-GTPases signaling. Int J Biochem Cell Biol. 2019;114:105572. https:\/\/doi.org\/10.1016\/j.biocel.2019.105572.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"2105_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbrc.2015.12.119","volume":"470","author":"C Jin","year":"2016","unstructured":"Jin C, Jin Z, Chen NZ, Lu M, Liu CB, Hu W, Le, et al. Activation of IRE1\u03b1-XBP1 pathway induces cell proliferation and invasion in colorectal carcinoma. Biochem Biophys Res Commun. 2016;470(1):75\u201381. https:\/\/doi.org\/10.1016\/j.bbrc.2015.12.119.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"2105_CR15","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.trecan.2020.07.006","volume":"6","author":"DP Raymundo","year":"2020","unstructured":"Raymundo DP, Doultsinos D, Guillory X, Carlesso A, Eriksson LA, Chevet E. Pharmacological targeting of IRE1 in Cancer. Trends in Cancer. 2020;6(12):1018\u201330. https:\/\/doi.org\/10.1016\/j.trecan.2020.07.006.","journal-title":"Trends in Cancer"},{"key":"2105_CR16","doi-asserted-by":"publisher","first-page":"E869","DOI":"10.1073\/pnas.1115623109","volume":"109","author":"BCS Cross","year":"2012","unstructured":"Cross BCS, Bond PJ, Sadowski PG, Jha BK, Zak J, Goodman JM, et al. The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule. Proc Natl Acad Sci U S A. 2012;109:E869\u201378. https:\/\/doi.org\/10.1073\/pnas.1115623109.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"46","key":"2105_CR17","doi-asserted-by":"publisher","first-page":"15692","DOI":"10.1074\/jbc.REV120.010218","volume":"295","author":"JMD Grandjean","year":"2020","unstructured":"Grandjean JMD, Wiseman RL. Small molecule strategies to harness the unfolded protein response: where do we go from here? J Biol Chem. 2020;295(46):15692\u2013711. https:\/\/doi.org\/10.1074\/jbc.REV120.010218.","journal-title":"J Biol Chem"},{"issue":"2","key":"2105_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/biomedicines9020156","volume":"9","author":"N Siwecka","year":"2021","unstructured":"Siwecka N, Rozp\u0119dek-Kami\u0144ska W, Wawrzynkiewicz A, Pytel D, Diehl JA, Majsterek I. The structure, activation and signaling of IRE1 and its role in determining cell fate. Biomedicines. 2021;9(2):156. https:\/\/doi.org\/10.3390\/biomedicines9020156.","journal-title":"Biomedicines"},{"issue":"4","key":"2105_CR19","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s12094-020-02463-y","volume":"23","author":"R Adibzadeh","year":"2020","unstructured":"Adibzadeh R, Golhin MS, Sari S, Mohammadpour H, Kheirbakhsh R, Muhammadnejad A, et al. Combination therapy with TiO2 nanoparticles and cisplatin enhances chemotherapy response in murine melanoma models. Clin Transl Oncol. 2020;23(4):738\u201349. https:\/\/doi.org\/10.1007\/s12094-020-02463-y.","journal-title":"Clin Transl Oncol"},{"issue":"11","key":"2105_CR20","doi-asserted-by":"publisher","first-page":"8246","DOI":"10.1002\/jcp.29479","volume":"235","author":"Z Mohammadalipour","year":"2020","unstructured":"Mohammadalipour Z, Rahmati M, Khataee A, Moosavi MA. Differential effects of N-TiO2 nanoparticle and its photo\u2010activated form on autophagy and necroptosis in human melanoma A375 cells. J Cell Physiol. 2020;235(11):8246\u201359. https:\/\/doi.org\/10.1002\/jcp.29479.","journal-title":"J Cell Physiol"},{"issue":"9","key":"2105_CR21","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1111\/cas.14532","volume":"111","author":"S Blondy","year":"2020","unstructured":"Blondy S, David V, Verdier M, Mathonnet M, Perraud A, Christou N. 5-Fluorouracil resistance mechanisms in colorectal cancer: from classical pathways to promising processes. Cancer Sci. 2020;111(9):3142\u201354. https:\/\/doi.org\/10.1111\/cas.14532.","journal-title":"Cancer Sci"},{"issue":"3","key":"2105_CR22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/cancers11030338","volume":"11","author":"E Bahar","year":"2019","unstructured":"Bahar E, Kim JY, Yoon H. Chemotherapy resistance explained through endoplasmic reticulum stress-dependent signaling. Cancers (Basel). 2019;11(3):338. https:\/\/doi.org\/10.3390\/cancers11030338.","journal-title":"Cancers (Basel)"},{"key":"2105_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.etap.2016.05.005","volume":"44","author":"JK Kim","year":"2016","unstructured":"Kim JK, Kang KA, Piao MJ, Ryu YS, Han X, Fernando PMDJ, et al. Endoplasmic reticulum stress induces 5-fluorouracil resistance in human colon cancer cells. Environ Toxicol Pharmacol. 2016;44:128\u201333. https:\/\/doi.org\/10.1016\/j.etap.2016.05.005.","journal-title":"Environ Toxicol Pharmacol"},{"issue":"1","key":"2105_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/ersc-2017-0001","volume":"4","author":"C Stewart","year":"2017","unstructured":"Stewart C, Estrada A, Kim P, Wang D, Wei Y, Gentile C, et al. Regulation of IRE1\u03b1 by the small molecule inhibitor 4\u00b58c in hepatoma cells. Endoplasmic Reticulum Stress Dis. 2017;4(1):1\u201310. https:\/\/doi.org\/10.1515\/ersc-2017-0001.","journal-title":"Endoplasmic Reticulum Stress Dis"},{"issue":"7","key":"2105_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrm2199","volume":"8","author":"D Ron","year":"2007","unstructured":"Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007;8(7):519\u201329. https:\/\/doi.org\/10.1038\/nrm2199.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2105_CR26","doi-asserted-by":"publisher","first-page":"e55865","DOI":"10.7554\/eLife.55865","volume":"9","author":"N Pavlovi\u0107","year":"2020","unstructured":"Pavlovi\u0107 N, Calitz C, Thanapirom K, Mazza G, Rombouts K, Gerwins P, et al. Inhibiting IRE1\u03b1-endonuclease activity decreases tumor burden in a mouse model for hepatocellular carcinoma. Elife. 2020;9:e55865. https:\/\/doi.org\/10.7554\/eLife.55865.","journal-title":"Elife"},{"key":"2105_CR27","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.biopha.2018.07.029","volume":"1","author":"S Zhang","year":"2018","unstructured":"Zhang S, Liu Y, Xiang D, Yang J, Liu D, Ren X, et al. Assessment of dose-response relationship of 5-fluorouracil to murine intestinal injury. Biomed Pharmacother. 2018;1:106:910\u20136. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.029.","journal-title":"Biomed Pharmacother"},{"issue":"48","key":"2105_CR28","doi-asserted-by":"publisher","first-page":"6738","DOI":"10.1038\/onc.2017.284","volume":"36","author":"X-X Li","year":"2017","unstructured":"Li X-X, Zhang H-S, Xu Y-M, Zhang R-J, Chen Y, Fan L, et al. Knockdown of IRE1\u03b1 inhibits colonic tumorigenesis through decreasing \u03b2-catenin and IRE1\u03b1 targeting suppresses colon cancer cells. Oncogene. 2017;36(48):6738\u201346. https:\/\/doi.org\/10.1038\/onc.2017.284.","journal-title":"Oncogene"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02105-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-023-02105-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02105-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T03:45:11Z","timestamp":1693453511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-023-02105-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,22]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["2105"],"URL":"https:\/\/doi.org\/10.1007\/s12032-023-02105-7","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,22]]},"assertion":[{"value":"29 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declares that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The project was approved by the ethical committee at NIMAD, Iran, by 1398.265 approval ID.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"247"}}